MS
Highly rated in
39
conditions
Highly rated in
39
conditions
Check Dr. Mustafa O. Sahin's experience treating your condition:
About Dr. Mustafa O. Sahin

Mustafa Sahin is a Neurologist and a Child Neurologist in Boston, Massachusetts. Sahin has been practicing medicine for over 27 years and is highly rated in 39 conditions, according to our data. His top areas of expertise are Tuberous Sclerosis, Tuberous Sclerosis Complex, Cortical Dysplasia, Autism Spectrum Disorder, and Abdominal Wall Surgery. He is licensed to treat patients in Massachusetts. Sahin is currently accepting new patients.

His clinical research consists of co-authoring 398 peer reviewed articles and participating in 17 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Mustafa O. Sahin it is best to call his office and ask if your insurance is accepted.


Dr. Mustafa O. Sahin accepts the following insurance:

  •  Ambetter
  •  Anthem
Locations
300 Longwood Ave, Fegan 11, Boston, MA 02115
Background & Education
Graduate Institution
Yale University School Of Medicine, 1995
Specialties
Neurology
Child Neurology
Licenses
Psychiatry & Neurology in MA
Hospital Affiliations
Brigham And Womens Hospital
Beth Israel Deaconess Medical Center
Boston Childrens Hospital
Languages Spoken
English
Greek
Spanish
Turkish
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


17 Clinical Trials

Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
Mapping the Genotype, Phenotype, and Natural History of Phelan-McDermid Syndrome
Pharmacological Treatment of Rett Syndrome by Stimulation of Synaptic Maturation With IGF-1
Pharmacological Treatment of Rett Syndrome by Stimulation of Synaptic Maturation With Recombinant Human IGF-1(Mecasermin [rDNA] Injection)
Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants
Biobanking of Rett Syndrome and Related Disorders Protocol
Randomized Double-Blind Phase 2 Trial Of RAD001 For Neurocognition In Individuals With Tuberous Sclerosis Complex
A Randomized Double-Blind Controlled Trial of Everolimus in Individuals With PTEN Mutations (RAD001XUS257T)
Mapping the Phenotype in Adults With Phelan-McDermid Syndrome
View 11 Less Clinical Trials -

398 Total Publications

GENE TARGET: A framework for evaluating Mendelian neurodevelopmental disorders for gene therapy.


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors